Generalizability of the EMBOLISE, MAGIC-MT, STEM, EMPROTECT, and MEMBRANE trials of middle meningeal artery embolization for chronic subdural hematoma: A single-center cohort analysis.
OBJECTIVE The pivotal EMBOLISE, MAGIC-MT, and STEM randomized trials (RCTs) established middle meningeal artery embolization (MMAE) for chronic subdural hematoma (cSDH) but used differing criteria of uncertain real-world representativeness, and two further RCTs (EMPROTECT, MEMBRANE) have since reported. We quantified h...